世界の3Dバイオプリンティング市場2021-2028:技術別(磁気浮上式、インクジェット式)、用途別(医療、歯科、バイオセンサー、バイオインク)、地域別

◆英語タイトル:3D Bioprinting Market Size, Share & Trends Analysis Report By Technology (Magnetic Levitation, Inkjet-based), By Application (Medical, Dental, Biosensors, Bioinks), By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC102
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月25日
◆ページ数:240
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の3Dバイオプリンティング市場規模が2028年までに44億ドルに達すると予測しています。2021年から2028年までに年平均15.8%成長する見通しです。本調査レポートでは、3Dバイオプリンティングの世界市場について調査・分析し、調査手法、エグゼクティブサマリー、市場変動・動向・範囲、技術別(磁気浮上式、インクジェット式、シリンジ式、レーザー式、その他)分析、用途別(医療、歯科、バイオセンサー、バイオインク、食品・動物製品)分析、地域別分析、競争状況などを掲載しています。
・調査手法
・エグゼクティブサマリー
・市場変動・動向・範囲
・3Dバイオプリンティングの世界市場規模:技術別(磁気浮上式、インクジェット式、シリンジ式、レーザー式、その他)
・3Dバイオプリンティングの世界市場規模:用途別(医療、歯科、バイオセンサー、バイオインク、食品・動物製品)
・3Dバイオプリンティングの世界市場規模:地域別
・競争状況
【レポートの概要】

3D Bioprinting Market Growth & Trends

The global 3D bioprinting market size is expected to reach USD 4.4 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.8% from 2021 to 2028. Rising cases of COVID-19 and increasing prevalence of chronic diseases are some of the major factors contributing towards market growth.

The COVID-19 epidemic is ever increasing since it was first identified in China in December 2019. Until January 12, 2021, more than 91.5 million cases of COVID-19 were reported globally, with more than 1,956,880 deaths, across the globe. This pandemic has fast tracked the development of vaccine and drug testing. There are currently more than 50 COVID-19 vaccine candidates in trials.

In the meantime, various 3D bioprinting companies are focused on research and development of artificial tissues. With the help of U-FAB, and other bioprinting technologies, CLECELL company has created respiratory epithelium artificial tissue which will help to prevent infection and tissue injury through the use of the mucociliary elevator. This pandemic has not only affected the well-being of people, but has also affected the economy, and various other healthcare infrastructures worldwide. This has severely disrupted the medical devices and pharmaceutical supply chains across the world. In such critical situation, various 3D bioprinting companies have created a global movement to supply emergency medical equipment such as ventilators, and personal protection equipment (PPE), to the healthcare workers.

North America held the highest share of the market, accounting for about 32.4% of the market share in 2020. Increasing adoption of 3D bioprinting for the production of medical products is expected to be one of the major factors contributing to market growth in this region. Whereas, Asia Pacific is anticipated to witness technological developments in pharmaceutical and biopharmaceutical sectors.

3D Bioprinting Market Report Highlights

• The medical segment accounted for the largest revenue share of 36.2% in 2020 due to the increasing investment made in R&D

• The magnetic levitation segment is anticipated to witness the highest CAGR of 17.0% over the forecast period due to technological development and increasing adoption of magnetic levitation technique by various innovators

• North America dominated the market in 2020 and accounted for the largest revenue share of 32.4%. Growing government expenditure on healthcare industry is one of the major factors driving the market

【レポートの目次】

Table of contents

Chapter 1 Research Methodology
1.1 Market Segmentation & Scope
1.2 Market Definition
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s internal database
1.3.3 Secondary technologys & third party perspectives
1.3.4 Primary research
1.4 Information Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Data Visualization
1.6 Data Validation & Publishing
Chapter 2 Executive Summary
2.1 3D Bioprinting Market Outlook, 2016 – 2028
Chapter 3 Industry Outlook: Market Variables, Trends, & Scope
3.1 Penetration &Growth Prospect Mapping For Magnetic Levitation Service, 2018
3.2 Trend Analysis
3.2.1 Technology trend
3.2.3 Application trend
3.2.4 Regional trend
3.3 3D Bioprinting Market: Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 Technological Advancement in the 3D Bioprinting Industry
3.3.1.2 Rising Prevalence of Chronic Disease
3.3.1.3 Increasing Use of 3D Bioprinting in the Pharmaceutical and Cosmetology
3.3.2 Market restraint analysis
3.3.2.1 The high cost of 3D bioprinters
3.3.2.2 Lack of trained professionals
3.4 Key Opportunity Analysis
3.5 Industry Analysis – Porter’s
3.5.1 Supplier Power
3.5.2 Buyer Power
3.5.3 Substitution Threat
3.5.4 New Entrants Threat
3.5.5 Competitive Rivalry
3.6 3D Bioprinting-SWOT Analysis, By PEST
3.6.1 Political landscape
3.6.2 Economic landscape
3.6.3 Social landscape
3.6.4 Technology landscape
3.7 3D Bioprinting Market: Company Share Analysis
3.8 Competitive Landscape
3.8.1 Strategy Framework
3.8.2 Company Categorization
3.8.3 New Entrants
3.8.4 Mature Players & Leaders
Chapter 4 3D Bioprinting Market: Technology Estimates & Trend Analysis
4.1 Global 3D Bioprinting Market: Technology Movement Analysis
4.2 Magnetic Levitation Technology
4.2.1 Global Magnetic Levitation technology market, 2016 – 2028 (USD Million)
4.3 Inkjet-based Technology
4.3.1 Global Inkjet-based technology market, 2016 – 2028 (USD Million)
4.4 Syringe-based Technology
4.4.1 Global Syringe-based technology market, 2016 – 2028 (USD Million)
4.5 Laser-based Technology
4.5.1 Global Laser-based technology market, 2016 – 2028 (USD Million)
4.6 Others
4.6.1 Global Other technologies market, 2016 – 2028 (USD Million)
Chapter 5 3D Bioprinting Market: Application Estimates & Trend Analysis
5.1 Global 3D Bioprinting Market: Application Movement Analysis
5.2 Medical
5.2.1 Global medical market, 2016 – 2028 (USD Million)
5.2.2 Tissue and organ generation
5.2.2.1 Global tissue and organ generation market, 2016 – 2028 (USD Million)
5.2.3 Medical pills
5.2.3.1 Global Medical pills market, 2016 – 2028 (USD Million)
5.2.4 Prosthetics and implants
5.2.4.1 Global Prosthetics and implants market, 2016 – 2028 (USD Million)
5.2.6 Others
5.2.6.1 Global other application market, 2016 – 2028 (USD Million)
5.3 Dental
5.3.1 Global dental market, 2016 – 2028 (USD Million)
5.4 Biosensors
5.4.1 Global biosensors market, 2016 – 2028 (USD Million)
5.5 Consumer/Personal Product Testing
5.5.1 Global consumer/personal product testing market, 2016 – 2028 (USD Million)
5.6 Bioinks
5.6.1 Global bioinks market, 2016 – 2028 (USD Million)
5.7 Food and Animal Product
5.7.1 Global food and animal market, 2016 – 2028 (USD Million)
Chapter 6 3D Bioprinting Market: Regional Estimates & Trend Analysis, by Service, Technology, & Application
6.1 3D Bioprinting Market Share By Region, 2020 & 2028
6.2 North America
6.2.1 North America 3D Bioprinting market, 2016 – 2028 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.2.2.2 U.S. 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.2.3 Canada
6.2.3.1 Canada 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.2.3.2 Canada 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.3 Europe
6.3.1 Europe 3D Bioprinting market, 2016 – 2028 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.3.2.2 U.K. 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.3.3 Germany
6.3.3.1 Germany 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.3.3.2 Germany 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.3.4 France
6.3.4.1 France 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.3.4.2 France 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.3.5 Italy
6.3.5.1 Italy 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.3.5.2 Italy 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.3.6 Spain
6.3.6.1 Spain 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.3.6.2 Spain 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific 3D Bioprinting market, 2016 – 2028 (USD Million)
6.4.2 Japan
6.4.2.1 Japan 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.4.2.2 Japan 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.4.3 China
6.4.3.1 China 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.4.3.2 China 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.4.4 India
6.4.4.1 India 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.4.4.2 India 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.4.5 Thailand
6.4.5.1 Thailand 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.4.5.2 Thailand 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.4.6.2 South Korea 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.5 Latin America
6.5.1 Latin America 3D Bioprinting market, 2016 – 2028 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.5.2.2 Brazil 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.5.3.2 Mexico 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.5.4.2 Argentina 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.5.5 Columbia
6.5.5.1 Columbia 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.5.5.2 Columbia 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.6 Middle East & Africa (MEA)
6.6.1 Middle East & Africa 3D Bioprinting market, 2016 – 2028 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.6.2.2 South Africa 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.6.3.2 Saudi Arabia 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
6.6.4 UAE
6.6.4.1 UAE 3D Bioprinting market, by technology, 2016 – 2028 (USD Million)
6.6.4.2 UAE 3D Bioprinting market, by applications, 2016 – 2028 (USD Million)
Chapter 7 Competitive Landscape
7.1 Company Profiles
7.1.1 3D Systems
7.1.1.1 Company overview
7.1.1.2 Financial performance
7.1.1.3 Application benchmarking
7.1.1.4 Strategic initiatives
7.1.2 Organovo
7.1.2.1 Company overview
7.1.2.2 Financial performance
7.1.2.3 Application benchmarking
7.1.2.4 Strategic initiatives
7.1.3 CELLINK
7.1.3.1 Company overview
7.1.3.2 Financial performance
7.1.3.3 Application benchmarking
7.1.3.4 Strategic initiatives
7.1.4 Envision TEC
7.1.4.1 Company overview
7.1.4.2 Financial performance
7.1.4.3 Application benchmarking
7.1.4.4 Strategic initiatives
7.1.5 Materialise NV
7.1.5.1 Company overview
7.1.5.2 Financial performance
7.1.5.3 Application benchmarking
7.1.5.4 Strategic initiatives
7.1.6 Bio3D Technologies
7.1.6.1 Company overview
7.1.6.2 Financial performance
7.1.6.3 Application benchmarking
7.1.6.4 Strategic initiatives
7.1.7 Oceanz 3D printing & Additive Manufacturing
7.1.7.1 Company overview
7.1.7.2 Financial performance
7.1.7.3 Application benchmarking
7.1.7.4 Strategic initiatives
7.1.8 Solidscape
7.1.8.1 Company overview
7.1.8.2 Financial performance
7.1.8.3 Application benchmarking
7.1.8.4 Strategic initiatives
7.1.9 Stratasys Ltd.
7.1.9.1 Company overview
7.1.9.2 Financial performance
7.1.9.3 Application benchmarking
7.1.9.4 Strategic initiatives
7.1.10 Voxeljet
7.1.10.1 Company overview
7.1.10.2 Financial performance
7.1.10.3 Application benchmarking
7.1.10.4 Strategic initiatives

List of Tables

TABLE 1 3D Bioprinting - Industry snapshot & Critical Success Factors (CSFs), 2016 - 2028
TABLE 2 Global 3D Bioprinting Market, 2016 - 2028 (USD Million)
TABLE 3 Global 3D Bioprinting Market estimates and forecasts by Technology, 2016 - 2028 (USD Million)
TABLE 4 Global 3D Bioprinting Market estimates and forecasts by Application, 2016 - 2028 (USD Million)
TABLE 5 3D Bioprinting- Key Market Restraint
TABLE 6 Production Outlook
TABLE 7 Intel Corporation - Production Outlook
TABLE 8 Global 3D Bioprinting inkjet-based market by region, 2016 - 2028 (USD Million)
TABLE 9 Global 3D Bioprinting magnetic levitation market by region, 2016 - 2028 (USD Million)
TABLE 10 Global 3D Bioprinting syringe-based market by region, 2016 - 2028 (USD Million)
TABLE 11 Global 3D Bioprinting laser-based market by region, 2016 - 2028 (USD Million)
TABLE 12 Global 3D Bioprinting other technologies-based market by region, 2016 - 2028 (USD Million)
TABLE 13 Global 3D Bioprinting demand in medical by region, 2016 - 2028 (USD Million)
TABLE 14 Global 3D Bioprinting demand in dental by region, 2016 - 2028 (USD Million)
TABLE 15 Global 3D Bioprinting demand in biosensors by region, 2016 - 2028 (USD Million)
TABLE 16 Global 3D Bioprinting demand in consumer/personal product testing by region, 2016 - 2028 (USD Million)
TABLE 17 Global 3D Bioprinting demand in bioinks by region, 2016 - 2028 (USD Million)
TABLE 18 Global 3D Bioprinting demand in food and animal product by region, 2016 - 2028 (USD Million)
TABLE 19 Global 3D Bioprinting demand in other applications by region, 2016 - 2028 (USD Million)
TABLE 20 North America 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 21 North America 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 22 U.S. 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 23 U.S. 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 24 Canada 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 25 Canada 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 26 Europe 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 27 Europe 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 28 Germany 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 29 Germany 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 30 U.K. 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 31 U.K. 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 32 France 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 33 France 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 34 Itlay 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 35 Itlay 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 36 Spain 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 37 Spain 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 38 Asia Pacific 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 39 Asia Pacific 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 40 China 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 41 China 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 42 India 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 43 India 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 44 Japan 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 45 Japan 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 46 Thailand 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 47 Thailand 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 48 South Korea 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 49 South Korea 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 50 Latin America 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 51 Latin America 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 52 Brazil 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 53 Brazil 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 54 Mexico 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 55 Mexico 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 56 Argentina 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 57 Argentina 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 58 Colombia 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 59 Colombia 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 60 MEA 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 61 MEA 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 62 South Africa 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 63 South Africa 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 64 Saudi Arabia 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 65 Saudi Arabia 3D Bioprinting market by application, 2016 - 2028 (USD Million)
TABLE 66 UAE 3D Bioprinting market by technology, 2016 - 2028 (USD Million)
TABLE 67 UAE 3D Bioprinting market by application, 2016 - 2028 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value-chain-based sizing & forecasting
FIG. 6 QFD modeling for market share assessment
FIG. 7 Market formulation & validation
FIG. 8 Commodity Flow Analysis
FIG. 9 Volume Price Analysis
FIG. 10 3D bioprinting market snapshot (2020)
FIG. 11 Market segmentation
FIG. 12 Penetration & growth prospect mapping
FIG. 13 Consumer behavior analysis
FIG. 14 Market driver relevance analysis (Current & future impact)
FIG. 15 Market restraint relevance analysis (Current & future impact)
FIG. 16 Porter’s five forces analysis
FIG. 17 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 18 3D bioprinting market technology outlook: Segment dashboard
FIG. 19 3D bioprinting market: Technology movement analysis
FIG. 20 Magnetic levitation market, 2016 - 2028 (USD Million)
FIG. 21 Inkjet-based market, 2016 - 2028 (USD Million)
FIG. 22 Syringe-based market, 2016 - 2028 (USD Million)
FIG. 23 Laser-based market, 2016 - 2028 (USD Million)
FIG. 24 Others market, 2016 - 2028 (USD Million)
FIG. 25 3D bioprinting market application outlook: Segment dashboard
FIG. 26 3D bioprinting market: Application movement analysis
FIG. 27 Medical market, 2016 - 2028 (USD Million)
FIG. 28 Tissue and organ generation market, 2016 - 2028 (USD Million)
FIG. 29 Medical pills market, 2016 - 2028 (USD Million)
FIG. 30 Prosthetic and implants market, 2016 - 2028 (USD Million)
FIG. 31 Dental market, 2016 - 2028 (USD Million)
FIG. 32 Biosensors market, 2016 - 2028 (USD Million)
FIG. 33 Consumer/personal product testing market, 2016 - 2028 (USD Million)
FIG. 34 Bioinks market, 2016 - 2028 (USD Million)
FIG. 35 Food and animal product market, 2016 - 2028 (USD Million)
FIG. 36 Regional market: Key takeaways
FIG. 37 Regional outlook, 2020 & 2028
FIG. 38 North America market, 2016 - 2028 (USD Million)
FIG. 39 U.S. market, 2016 - 2028 (USD Million)
FIG. 40 Canada market, 2016 - 2028 (USD Million)
FIG. 41 Europe market, 2016 - 2028 (USD Million)
FIG. 42 U.K. market, 2016 - 2028 (USD Million)
FIG. 43 Germany market, 2016 - 2028 (USD Million)
FIG. 44 France market, 2016 - 2028 (USD Million)
FIG. 45 Italy market, 2016 - 2028 (USD Million)
FIG. 46 Spain market, 2016 - 2028 (USD Million)
FIG. 47 Asia Pacific market, 2016 - 2028 (USD Million)
FIG. 48 Japan market, 2016 - 2028 (USD Million)
FIG. 49 China market, 2016 - 2028 (USD Million)
FIG. 50 India market, 2016 - 2028 (USD Million)
FIG. 51 Thailand market, 2016 - 2028 (USD Million)
FIG. 52 South Korea market, 2016 - 2028 (USD Million)
FIG. 53 Latin America market, 2016 - 2028 (USD Million)
FIG. 54 Brazil market, 2016 - 2028 (USD Million)
FIG. 55 Mexico market, 2016 - 2028 (USD Million)
FIG. 56 Argentina market, 2016 - 2028 (USD Million)
FIG. 57 Colombia market, 2016 - 2028 (USD Million)
FIG. 58 MEA market, 2016 - 2028 (USD Million)
FIG. 59 South Africa market, 2016 - 2028 (USD Million)
FIG. 60 Saudi Arabia market, 2016 - 2028 (USD Million)
FIG. 61 UAE market, 2016 - 2028 (USD Million)
FIG. 62 Regional network map

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の3Dバイオプリンティング市場2021-2028:技術別(磁気浮上式、インクジェット式)、用途別(医療、歯科、バイオセンサー、バイオインク)、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆